The number of HTLV-1 infected persons in the world has recently been estimated to be at
least at 5 to 10 million or perhaps higher due to unavailable data (Gessain and Cassar Front …

The human T-cell leukemia virus type 1 (HTLV-1), identified as the first human oncogenic
retrovirus 30 years ago, is not an ubiquitous virus. HTLV-1 is present throughout the world …

HTLV-1 was the first described human retrovirus and was soon found to be associated with
severe clinical diseases, including a devastating lymphoma/leukemia and other …

It is 30 years since human T-cell leukemia virus type 1 (HTLV-1) was identified as the first
human retrovirus. To assess the implications of the virus for human health it is very important …

Human T-cell lymphotropic virus type 1 (HTLV-1) infection is spreading globally at an
uncertain speed. Sexual, mother-to-child, and parenteral exposure are the major …

Because HTLV-I, HTLV-2, and HIV share identical modes of transmission, simultaneous or
subsequent infections with these retroviruses are to be expected. The population of Santos …

Background HTLV-1 is endemic in Guinea-Bissau, and the highest prevalence in the adult
population (5.2%) was observed in a rural area, Caió, in 1990. HIV-1 and HIV-2 are both …

Aims To assess the prevalence of HTLV-1 and HTLV-2 infections in a cohort of immigrants
living in southern Italy. Findings We screened for antibody to HTLV-1/2 infection 1,498 …

Background: Infection with Human T-cell Lymphotropic virus type 1 and 2 (HTLV-1/2) is a
global epidemic. Nigeria is in the endemic region of HTLV-1/2 infections. The diseases …

Human T cell lymphotropic virus type 2 (HTLV-2) infection is endemic in the American Indian
population and Pygmy tribes in Africa. Nevertheless, HTLV-2 infection has been …